Generic Name: Ticagrelor
Brand Name: Brilinta
Manufacturer: AstraZeneca Canada Inc
Therapeutic Area: Acute Coronary Syndromes
Indications: Acute Coronary Syndromes (ACS)
Submission Type: Initial
Project Status: Cancelled
CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
Generic Name: Ticagrelor
Brand Name: Brilinta
Manufacturer: AstraZeneca Canada Inc
Therapeutic Area: Acute Coronary Syndromes
Indications: Acute Coronary Syndromes (ACS)
Submission Type: Initial
Project Status: Cancelled